Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ROCKWELL MEDICAL, INC. (RMTI)

$6.63 +1.61% NASDAQ: RMTI · 15-min delayed
  • WIXOM, Michigan
  • Public · NASDAQ: RMTI
  • 157 employees
$26.2MMarket cap
-$5.3MNet income
157Employees
RMTINASDAQ
1998IPO

About ROCKWELL MEDICAL, INC.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$5.3M
Total assets
$57.1M
Market cap
$26.2M
Gross margin
16.9%
Operating margin
-6.8%
Net margin
-7.7%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$69.3M
Cost of revenue
$57.6M
Gross profit
$11.7M
Operating expenses
$16.4M
Operating income
-$4.7M
Income tax
$0
Net income
-$5.3M
EPS (basic)
$-0.15
EPS (diluted)
$-0.15

Balance sheet

Total assets
$57.1M
Current assets
$38.2M
Total liabilities
$20.2M
Current liabilities
$9.6M
Shareholders’ equity
$37.0M

Cash flow

Operating cash flow
-$659.0K
Investing cash flow
-$8.5M
Financing cash flow
$4.3M
Net cash flow
-$5.0M

Statements via Polygon.io (SEC filings)

NASDAQ: RMTI
$6.63 +1.61%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.19 $18.30

52-week range

Market cap
$26.2M
EPS (diluted)
$-0.15
Shares outstanding
4.0M
Open
Day range
Prev close
Volume
IPO date
Jan 27, 1998

Rockwell Medical, Inc. (RMTI) Stock Price

  • Reported a net loss of $5.3M.
  • Revenue grew 12% from FY2021 to FY2025.
  • Gross margin of 16.9%, net margin -7.7%.
  • Trading 64% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ROCKWELL MEDICAL, INC..

Write a review
Newsroom

News about ROCKWELL MEDICAL, INC.

News & sentiment via Polygon.io

FAQ

Rockwell Medical, Inc.: frequently asked questions

Is Rockwell Medical, Inc. an American company?

Rockwell Medical, Inc. is a US-based company headquartered in Wixom, Michigan, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Rockwell Medical, Inc. headquartered?

Rockwell Medical, Inc. is headquartered in Wixom, Michigan, United States.

Is Rockwell Medical, Inc. publicly traded?

Yes — Rockwell Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol RMTI on the NASDAQ.

What does Rockwell Medical, Inc. do?

Rockwell Medical, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →